Europe risks missing its biotech moment – time to act now! 

As the European Commission prepares its long-awaited Biotech Act, US voices from industry, academia and advocacy warn that while Europe leads in science, it lags in translation. According to their response to the Commission’s call for evidence, fragmented rules, complex clinical trial systems, and regulatory delays are stifling innovation. At the BIO International Convention in Boston, Commissioner Olivér Várhelyi echoed the urgency: “We have to make it easier to innovate in Europe. We have to make it easier to manufacture in Europe. And we have to make it much faster for therapies to get to patients.” Hollandbio supports this momentum through a brand-new EU Biotech Act campaign, advocating for bold policy changes to unlock biotech innovation across Europe, and giving you a chance to have your voice heard too. Join us today in urging the EU to act now for a bright biotech future!